{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:40:50Z","timestamp":1786635650596,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijo.ijo_843_16","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T02:19:28Z","timestamp":1494987568000},"page":"311","source":"Crossref","is-referenced-by-count":22,"title":["Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India"],"prefix":"10.4103","volume":"65","author":[{"given":"Pukhraj","family":"Rishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Maitray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Dhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishvesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Munusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.206335-1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/archopht.1958.00940080917010","article-title":"The treatment of retinoblastoma by X-ray and triethylene melamine","author":"Reese","year":"1958","journal-title":"AMA Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.206335-2","first-page":"1829","article-title":"Retrograde infusion of anti-cancer drugs to ophthalmic artery for intraocular malignant tumors","author":"Kiribuchi","year":"1966","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"key-10.4103\/0301-4738.206335-3","first-page":"858","article-title":"Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay","author":"Inomata","year":"1987","journal-title":"Jpn J Cancer Res"},{"key":"key-10.4103\/0301-4738.206335-4","doi-asserted-by":"crossref","unstructured":"Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology 2008;115:1398-404, 1404.e1.","DOI":"10.1016\/j.ophtha.2007.12.014"},{"key":"key-10.4103\/0301-4738.206335-5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/0301-4738.158076","article-title":"Intra-arterial chemotherapy for retinoblastoma:First Indian report","author":"Rishi","year":"2015","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.206335-6","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2011.03.013","article-title":"Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: The long-term prognosis","author":"Suzuki","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.206335-7","doi-asserted-by":"crossref","first-page":"e0146582","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group d retinoblastoma","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"key":"key-10.4103\/0301-4738.206335-8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.ophtha.2014.01.026","article-title":"Intra-arterial chemotherapy for retinoblastoma in 70 eyes: Outcomes based on the international classification of retinoblastoma","author":"Shields","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.206335-9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaapos.2016.05.009","article-title":"Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: Long-term tumor control and globe salvage in 30 eyes","author":"Say","year":"2016","journal-title":"J AAPOS"},{"key":"key-10.4103\/0301-4738.206335-10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.206335-11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ophtha.2014.11.029","article-title":"Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma","author":"Francis","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.206335-12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: From prohibition to conditional indications","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.206335-13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.206335-14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: Preliminary results","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.206335-15","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: Outcomes after 192 consecutive injections.The 2015 Howard Naquin Lecture","author":"Shields","year":"2016","journal-title":"Retina"},{"key":"key-10.4103\/0301-4738.206335-16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0301-4738.154369","article-title":"Retinoblastoma: Achieving new standards with methods of chemotherapy","author":"Kaliki","year":"2015","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:48:32Z","timestamp":1786632512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_843_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["206335"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_843_16","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}